Notice: This company has been marked as potentially delisted and may not be actively trading. Sinovac Biotech (SVA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOptions ChainOwnershipTrendsBuy This Stock SVA vs. MIRM, GMTX, EWTX, CNTA, LGND, BLTE, ARWR, ARQT, HRMY, and TVTXShould you be buying Sinovac Biotech stock or one of its competitors? The main competitors of Sinovac Biotech include Mirum Pharmaceuticals (MIRM), Gemini Therapeutics (GMTX), Edgewise Therapeutics (EWTX), Centessa Pharmaceuticals (CNTA), Ligand Pharmaceuticals (LGND), Belite Bio (BLTE), Arrowhead Pharmaceuticals (ARWR), Arcutis Biotherapeutics (ARQT), Harmony Biosciences (HRMY), and Travere Therapeutics (TVTX). These companies are all part of the "pharmaceutical preparations" industry. Sinovac Biotech vs. Mirum Pharmaceuticals Gemini Therapeutics Edgewise Therapeutics Centessa Pharmaceuticals Ligand Pharmaceuticals Belite Bio Arrowhead Pharmaceuticals Arcutis Biotherapeutics Harmony Biosciences Travere Therapeutics Sinovac Biotech (NASDAQ:SVA) and Mirum Pharmaceuticals (NASDAQ:MIRM) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, community ranking, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Does the media refer more to SVA or MIRM? In the previous week, Mirum Pharmaceuticals had 5 more articles in the media than Sinovac Biotech. MarketBeat recorded 7 mentions for Mirum Pharmaceuticals and 2 mentions for Sinovac Biotech. Mirum Pharmaceuticals' average media sentiment score of 1.29 beat Sinovac Biotech's score of 0.00 indicating that Mirum Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sinovac Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mirum Pharmaceuticals 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend SVA or MIRM? Mirum Pharmaceuticals has a consensus target price of $58.20, indicating a potential upside of 29.19%. Given Mirum Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Mirum Pharmaceuticals is more favorable than Sinovac Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sinovac Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Mirum Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Which has more risk & volatility, SVA or MIRM? Sinovac Biotech has a beta of 0.01, meaning that its stock price is 99% less volatile than the S&P 500. Comparatively, Mirum Pharmaceuticals has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Is SVA or MIRM more profitable? Sinovac Biotech has a net margin of 0.00% compared to Mirum Pharmaceuticals' net margin of -31.69%. Sinovac Biotech's return on equity of 0.00% beat Mirum Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Sinovac BiotechN/A N/A N/A Mirum Pharmaceuticals -31.69%-41.22%-14.81% Which has higher valuation and earnings, SVA or MIRM? Sinovac Biotech has higher revenue and earnings than Mirum Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSinovac Biotech$448.27M1.44-$99.92MN/AN/AMirum Pharmaceuticals$336.89M6.55-$163.41M-$1.85-24.35 Does the MarketBeat Community favor SVA or MIRM? Sinovac Biotech received 125 more outperform votes than Mirum Pharmaceuticals when rated by MarketBeat users. However, 75.86% of users gave Mirum Pharmaceuticals an outperform vote while only 67.99% of users gave Sinovac Biotech an outperform vote. CompanyUnderperformOutperformSinovac BiotechOutperform Votes25767.99% Underperform Votes12132.01% Mirum PharmaceuticalsOutperform Votes13275.86% Underperform Votes4224.14% SummaryMirum Pharmaceuticals beats Sinovac Biotech on 9 of the 15 factors compared between the two stocks. Remove Ads Get Sinovac Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SVA vs. The Competition Export to ExcelMetricSinovac BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$644.67M$6.90B$5.64B$7.80BDividend YieldN/A2.80%5.34%4.03%P/E RatioN/A7.4223.6318.68Price / Sales1.44206.91370.1089.74Price / Cash38.9565.6738.1734.64Price / Book0.056.216.744.12Net Income-$99.92M$142.11M$3.20B$247.10M Sinovac Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SVASinovac BiotechN/A$6.47flatN/AN/A$644.67M$448.27M0.003,261High Trading VolumeMIRMMirum Pharmaceuticals4.3727 of 5 stars$47.02flat$58.20+23.8%+83.1%$2.30B$336.89M-23.28140News CoveragePositive NewsGMTXGemini TherapeuticsN/A$52.24-1.9%N/A-15.9%$2.26BN/A-52.2430High Trading VolumeEWTXEdgewise Therapeutics1.9095 of 5 stars$23.37-1.0%$45.38+94.2%+27.6%$2.22BN/A-15.5860CNTACentessa Pharmaceuticals3.0916 of 5 stars$16.63+5.6%$26.00+56.3%+29.1%$2.19B$6.85M-10.87200Earnings ReportAnalyst ForecastAnalyst RevisionLGNDLigand Pharmaceuticals4.4733 of 5 stars$111.67+3.3%$147.00+31.6%+47.2%$2.15B$167.13M44.4980Short Interest ↑Positive NewsBLTEBelite Bio2.1835 of 5 stars$66.94-0.5%$96.33+43.9%+73.8%$2.13BN/A-60.3110ARWRArrowhead Pharmaceuticals3.4268 of 5 stars$15.50+4.7%$41.44+167.4%-51.7%$2.13B$2.50M-3.00400Gap DownARQTArcutis Biotherapeutics2.6618 of 5 stars$17.29+1.6%$18.80+8.7%+58.7%$2.05B$196.54M-9.66150Short Interest ↓Positive NewsGap DownHRMYHarmony Biosciences4.4573 of 5 stars$34.24-2.9%$53.33+55.8%-1.2%$1.96B$714.73M16.23200TVTXTravere Therapeutics2.7276 of 5 stars$21.29+3.7%$30.62+43.8%+155.3%$1.89B$233.18M-5.19460Positive News Remove Ads Related Companies and Tools Related Companies MIRM Alternatives GMTX Alternatives EWTX Alternatives CNTA Alternatives LGND Alternatives BLTE Alternatives ARWR Alternatives ARQT Alternatives HRMY Alternatives TVTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SVA) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinovac Biotech Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sinovac Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
